Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thor Haahr

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Human Reproduction (Oxford, England)|February 3, 2021
Analysing endometrial microbiome: methodological considerations and recommendations for good practiceNerea M Molina, Alberto Sola-Leyva, Thor Haahr, et al.
Panminerva Medica|July 3, 2018
Freeze-all strategy in IVF/ICSI cycles: an update on clinical utilityMatheus Roque, Beatrice Nuto Nóbrega, Marcello Valle, et al.
Reproductive Biomedicine Online|May 24, 2017
Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled studyBirgit Alsbjerg, Helle Olesen Elbaek, Rita Jakubcionyte Laursen, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|September 2, 2021
The combined effect of lifestyle intervention and antioxidant therapy on sperm DNA fragmentation and seminal oxidative stress in IVF patients: a pilot studyPeter Humaidan, Thor Haahr, Betina Boel Povlsen, et al.
BMJ Open|October 14, 2020
Effect of clindamycin and a live biotherapeutic on the reproductive outcomes of IVF patients with abnormal vaginal microbiota: protocol for a double-blind, placebo-controlled multicentre trialThor Haahr, Nina La Cour Freiesleben, Anja Pinborg, et al.
Viruses|October 14, 2020
Characterization of the Vaginal DNA Virome in Health and DysbiosisRasmus Riemer Jakobsen, Thor Haahr, Peter Humaidan, et al.
The Journal of Infectious Diseases|January 1, 2019
Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive OutcomeThor Haahr, Peter Humaidan, Helle Olesen Elbaek, et al.
The Journal of Infectious Diseases|January 23, 2020
Corrigendum to: Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive OutcomeThor Haahr, Peter Humaidan, Helle Olesen Elbaek, et al.
Reproductive Biomedicine Online|May 1, 2021
The exogenous progesterone-free luteal phase: two pilot randomized controlled trials in IVF patientsPeter Humaidan, Birgit Alsbjerg, Helle Olesen Elbaek, et al.
Acta Obstetricia Et Gynecologica Scandinavica|June 4, 2016
Treatment of bacterial vaginosis in pregnancy in order to reduce the risk of spontaneous preterm delivery - a clinical recommendationThor Haahr, Anne S Ersbøll, Mona A Karlsen, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Human Reproduction (Oxford, England)|February 3, 2021
Analysing endometrial microbiome: methodological considerations and recommendations for good practiceNerea M Molina, Alberto Sola-Leyva, Thor Haahr, et al.
Panminerva Medica|July 3, 2018
Freeze-all strategy in IVF/ICSI cycles: an update on clinical utilityMatheus Roque, Beatrice Nuto Nóbrega, Marcello Valle, et al.
Reproductive Biomedicine Online|May 24, 2017
Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled studyBirgit Alsbjerg, Helle Olesen Elbaek, Rita Jakubcionyte Laursen, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|September 2, 2021
The combined effect of lifestyle intervention and antioxidant therapy on sperm DNA fragmentation and seminal oxidative stress in IVF patients: a pilot studyPeter Humaidan, Thor Haahr, Betina Boel Povlsen, et al.
BMJ Open|October 14, 2020
Effect of clindamycin and a live biotherapeutic on the reproductive outcomes of IVF patients with abnormal vaginal microbiota: protocol for a double-blind, placebo-controlled multicentre trialThor Haahr, Nina La Cour Freiesleben, Anja Pinborg, et al.
Viruses|October 14, 2020
Characterization of the Vaginal DNA Virome in Health and DysbiosisRasmus Riemer Jakobsen, Thor Haahr, Peter Humaidan, et al.
The Journal of Infectious Diseases|January 1, 2019
Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive OutcomeThor Haahr, Peter Humaidan, Helle Olesen Elbaek, et al.
The Journal of Infectious Diseases|January 23, 2020
Corrigendum to: Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive OutcomeThor Haahr, Peter Humaidan, Helle Olesen Elbaek, et al.
Reproductive Biomedicine Online|May 1, 2021
The exogenous progesterone-free luteal phase: two pilot randomized controlled trials in IVF patientsPeter Humaidan, Birgit Alsbjerg, Helle Olesen Elbaek, et al.
Acta Obstetricia Et Gynecologica Scandinavica|June 4, 2016
Treatment of bacterial vaginosis in pregnancy in order to reduce the risk of spontaneous preterm delivery - a clinical recommendationThor Haahr, Anne S Ersbøll, Mona A Karlsen, et al.
Pageof 5